Table 2.
Patient number | Phenotype | Mutation of ABCD1 | Effect of mutation of ABCD1 | Position of mutation |
---|---|---|---|---|
13 | CCALD | 709C>T | S108L | Loop1 |
14 | CCALD | 709C>T | S108L | Loop1 |
15 | CCALD | 829A>G | N148S | TM2 |
16 | CCALD | 1026A>G | N214D | TM3 |
17 | CCALD | 1182G>A | G266R | Between TM4 and EAA-like |
18 | CCALD | 1324T>Ca | L313P | Between EAA-like and TM5 |
19 | CCALD | 1938C>T | R518W | Walker A |
20 | CCALD | 1939G>A | R518Q | Walker A |
21 | CCALD | 2017A>G | Q544R | Between Walker A and Cons |
22 | CCALD | 2017A>G | Q544R | Between Walker A and Cons |
23 | CCALD | 2065C>T | P560L | Between Walker A and Cons |
24 | CCALD | 2065C>T | P560L | Between Walker A and Cons |
25 | CCALD | Del. 2145–2156 | Del. HILQ587-590 | Between Walker A and Cons |
26 | AdultCer | Del. 1257–1259 | Del.E291 | EAA-like |
27 | AdultCer | 2005T>C | F540S | Between Walker A and Cons |
28 | AdultCer | 2358C>T | R660W | C-terminal to Walker B |
29 | AdultCer | 2385C>A | H667N | C-terminal to Walker B |
30 | AMN-Cer | 1146A>C | T254P | TM4 |
31 | AMN | 636C>T | P84S | TM1 |
32 | AMN | 709C>T | S108L | Loop1 |
33 | AMN | 1182G>A | G266R | Between TM4 and EAA-like |
34 | AMN | 1197G>A | E271K | Between TM4 and EAA-like |
35 | AMN | 1215G>Aa | G277R | Between TM4 and EAA-like |
36 | AMN | 1255C>G | S290W | EAA-like |
37 | AMN | 1581C>T | R401W | Between TM6 and Walker A |
38 | AMN | 2233C>A | A616D | Cons |
39 | AMN | 2385C>A | H667N | C-terminal to Walker B |
40 | Asymptomatic | 2211G>A | E609K | Cons |
Amino acid residue numbers in ALDP are based on Mosser et al. [1]. The domains and motifs in the ALDP are based on Mosser et al. [1]
CCALD childhood cerebral ALD, AdultCer adult with cerebral ALD, AMN-Cer AMN with cerebral ALD, AMN adrenomyeloneuropathy, TM transmembrane domain, Loop 1 loop 1 motif, EAA-like EAA-like protein motif, Walker A Walker A motif, Cons nucleotide binding fold conserved sequence, Walker B Walker B motif
aNovel mutation